Based on this YouTube video's total view count of 514K views and industry-standard rates, the estimated total earning is $360 - $1.03K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Spike after 700 days with 514,785 views, 40,716 likes, and 6,098 comments. Experience the impact of this video content that has captured audience attention.

Yale researchers recognise post-vaccination syndrome (PVS) Press release from Yale, Feb 19, 2025 https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination https://www.medrxiv.org/content/10.1101/2025.02.18.25322379v1 Chronic symptoms that developed a day or two soon after receiving a COVID-19 vaccine, can become more severe in the days that follow, PVS, little-understood, persistent condition, remains unrecognized by medical authorities. Common chronic symptoms of PVS Excessive fatigue (85%) Tingling and numbness (80%) Exercise intolerance (80%) Brain fog (77.5%) Difficulty concentrating or focusing (72.5%) Trouble falling or staying asleep (70%) Neuropathy (70%) Muscle aches (70%) Anxiety (65%) Tinnitus (60%) Burning sensations (57.5%). Getting out of breath Palpitations Headache Dizziness Lower quality of life scores Mechanisms Vaccine-induced immune responses may be triggering the stimulation of autoreactive lymphocytes. Unregulated stimulation of innate immunity could lead to chronic inflammation. Participants with PVS have a distinct set of autoantibodies. A subset of non-classical monocytes has been shown to harbor S protein in patients with PVS Biodistribution studies on mRNA–LNP platforms in indicate its ability to cross the blood-brain barrier, and the local S expression could result in neurocognitive symptoms. Compared with controls PVS had reduced circulating memory and effector CD4 T cells, and an increase in TNFα+ CD8 T cells. Serological evidence of recent Epstein-Barr virus (EBV) reactivation, more frequent in PVS. Measured levels of SARS-CoV-2 spike protein Participants with PVS had significantly higher circulating S1 levels compared with the control group (p = 0.01). PVS, (even those without evidence for infection), higher levels of spike protein than controls. Detectable S1 was found in participants' plasma ranging from 26 to 709 days from the most recent known vaccination. “That was surprising, to find spike protein in circulation at such a late time point,” (Some PVS patients didn’t have any measurable spike protein). Autoimmunity, tissue damage, Epstein-Barr Virus (EBV) reactivation, (infectious mononucleosis) https://www.medrxiv.org/content/Immunological and Antigenic Signatures Associated with Chronic Illnesses after1 COVID-19 Vaccination.pdf Yale LISTEN study. LISTEN stands for Listen to Immune, Symptom and Treatment Experiences Now. https://medicine.yale.edu/ycci/listen-study/ 42 LISTEN PVS patients (some never infected) 22 who did not report any PVS symptoms after COVID-19 vaccination. “It’s clear that some individuals are experiencing significant challenges after vaccination. Our responsibility as scientists and clinicians is to listen to their experiences, rigorously investigate the underlying causes, and seek ways to help,”

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.